Form 4: Traws Pharma Director Receives Stock Grant
Insider Transaction (Form 4)
Trafford Clarke, a Director of Traws Pharma, Inc., received 14,150 shares of common stock on July 9, 2026.
Summary
- Grant/award: acquired 14,150 Stock Option (right to buy) on July 9, 2026; holds 14,150 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Trafford Clarke — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-09 | Grant/award | Stock Option (right to buy) | 14,150 | — | — | 14,150 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-09 | Grant/award (14,150 shares) |
Keywords
insider transaction, Form 4, TRAW, Traws Pharma, Inc., neutral, Trafford Clarke
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.